Abstract: A valve includes a body that has a longitudinal axis. The body includes a conical portion positioned at an end of the body. The conical portion at least partially surrounds the body. The body includes a planar face circumferentially adjacent the conical portion. The planar face is angled with respect to the longitudinal axis of the body.

Abstract: A replaceable valve includes a spring preload adjuster and a spring. The spring is configured to be positioned at a first side of the spring preload adjuster. The replaceable valve includes a valve cap positioned at a second, opposite side of the spring preload adjuster. The valve cap is configured to attach to a shock absorber.

Abstract: A system for monitoring a fetus in a pregnant woman, and/or the maternal health risk for pregnancies complicated by such as pre-eclampsia and hypertensive disorders is configured to be worn by the pregnant woman, preferably so as to allow monitoring during daily life, e.g. in the form of an adhesive patch. The unit has a sound sensor, e.g. a microphone or accelerometer, to be positioned on the skin of the abdominal area so as to detect a vascular sound from umbilical arteries of the fetus or from the uterine arteries of the pregnant woman. The sound sensor is functionally connected to a processing unit which executes a processing algorithm on the captured vascular sound and extracts a signal parameter accordingly. The processing unit then communicates the signal parameter, e.g. using an audio signal, a visual display or by means of a wired or a wireless data signal.

Abstract: A system for omni-orientational wireless energy transfer is described. A transmitter unit has a transmitter resonator with a coil that is configured to be coupled to a power supply to wirelessly transmit power to a receiver unit. A receiver unit has a receiver resonator with a coil coupled to a device load. At least one of the resonators is a non-planar resonator that spans a non-degenerate two-dimensional surface having at least one concave portion.

Abstract: A blood pump includes a hub having an axis of rotation and a generally cylindrical shape. The hub has an upstream end region, a central region, and a downstream end region, and the hub includes a magnetic material. Blades that are disposed on the downstream end region of the hub extend downstream of the hub.

Abstract: An active implantable medical device for neurostimulation therapy is disclosed. The device produces stimulation pulse sequences generated continuously in succession during activity periods separated by intermediate inactivity periods during which no stimulation is issued. An input signal, provided by a physiological sensor, representative of cardiac activity and/or of the patient's hemodynamic status is received by circuitry. The circuitry further provides for dynamic control of the neurostimulation therapy, wherein the length of activity periods is modulated based on the current value level of the control parameter compared to a threshold. The duration of the next period of inactivity is calculated by the circuitry at the end of each activity period to maintain a constant duty cycle ratio between periods of activity and periods of inactivity.

Abstract: Provided is an intermetallic dielectric layer structure of a silicon-on-insulator device, comprising a silicon-rich oxide layer (54) covering a metal interconnect, a fluorine-silicon glass layer on the silicon-rich oxide layer, and a non-doped silicate glass layer on the fluorine-silicon glass layer; the thickness of the silicon-rich oxide layer (54) is 700 angstroms ±10%; the silicon-rich oxide layer having a greater thickness captures movable ions on an unsaturated bond, such that it is difficult for the movable ions to pass through the silicon-rich oxide layer, thus blocking the movable ions. The present invention has good performance in an integrity evaluation of the gate oxide layer, and avoids damage to the device caused by the aggregation of movable ions at an interface. Also provided are a silicon-on-insulator device and a method of manufacturing the intermetallic dielectric layer of the silicon-on-insulator device.

Abstract: Refining assemblies and methods for refining rich natural gas containing a first methane gas and other hydrocarbons that are heavier than methane gas are disclosed. In some embodiments, the assemblies may include a methane-producing assembly configured to receive at least one liquid-containing feed stream that includes water and rich natural gas and to produce an output stream therefrom by (a) converting at least a substantial portion of the other hydrocarbons of the rich natural gas with the water to a second methane gas, a lesser portion of the water, and other gases, and (b) allowing at least a substantial portion of the first methane gas from the rich natural gas to pass through the methane-producing assembly unconverted. The assemblies may additionally include a purification assembly configured to receive the output stream and to produce a methane-rich stream therefrom having a greater methane concentration than the output stream.

Abstract: The present invention relates to a long non-coding BARD1 RNA molecule named BARD1 9?L. The present invention also relates to siRNAs for therapeutic use, for example, the regulation of BARD1 expression by non-coding RNA. The present invention further relates to methods for the detection of BARD1 9?L. Finally, the present invention relates to promoters driving the expression of BARD1 9?L.

Abstract: Systems for tuning a wireless power transfer system are provided, which may include any number of features. In one embodiment, a TET system includes a receive resonator is adapted to be implanted in a human patient and is configured to receive wireless power from a transmit resonator. The system can include a controller configured to identify if a foreign object is interfering with the transmission of power or generating an induced voltage in the receiver resonator. The controller can also be configured to control the transmit resonator to phase match with the foreign object. Methods of use are also provided.

Abstract: An electronic device with a touch-sensitive surface, a display, and one or more sensors to detect intensity of contacts: displays a plurality of user interface objects in a first user interface; detects a contact at a location of a first user interface object; and: detects an increase in a characteristic intensity of the contact to a first intensity threshold; in response, visually obscures the plurality of user interface objects, other than the first user interface object, while maintaining display of the first user interface object; detects that the characteristic intensity of the contact continues to increase above the first intensity threshold; and, in response, dynamically increases the amount of visual obscuring of the plurality of user interface objects, other than the first user interface object.

Abstract: In various embodiments, an electronic device, a method, and a non-transitory computer-readable media are provided for storing a plurality of applications including an application, utilizing the memory; displaying indicia; when a first pressure being applied to the touch screen is detected as ceasing in connection with the indicia, performing an operation; when a second pressure being applied to the touch screen is detected in connection with the indicia after the first pressure is detected without the ceasing, outputting feedback that is perceptible by touch; when the second pressure being applied to the touch screen is detected in connection with the indicia after the first pressure is detected without the ceasing, performing another operation; when a third pressure being applied to the touch screen is detected in connection with the indicia after the second pressure is detected, outputting additional feedback that is perceptible by touch; when the third pressure being applied to the touch screen is detected

Abstract: The present invention relates to multimeric mannosides, a process for preparing the same and their uses in medicine for treating Escherichia coli infections.

Abstract: The invention relates to the novel long non-coding BARD1 RNA molecule BARD1 9?L, siRNAs for therapeutic use and methods for the detection of BARD1 9?L as well as a promoters driving the expression of BARD1 9?L.

Abstract: Hydrogen generation assemblies, hydrogen purification devices, and their components are disclosed. In some embodiments, the devices may include a permeate frame with a membrane support structure having first and second membrane support plates that are free from perforations and that include a plurality of microgrooves configured to provide flow channels for at least part of the permeate stream. In some embodiments, the assemblies may include a return conduit fluidly connecting a buffer tank and a reformate conduit, a return valve assembly configured to manage flow in the return conduit, and a control assembly configured to operate a fuel processing assembly between run and standby modes based, at least in part, on detected pressure in the buffer tank and configured to direct the return valve assembly to allow product hydrogen stream to flow from the buffer tank to the reformate conduit when the fuel processing assembly is in the standby mode.

Abstract: A method is disclosed for determining a minimum connected dominating set in a graph, the method comprising obtaining an indication of an input graph, the input graph comprising a plurality of nodes and a plurality of edges; generating a distance table comprising for each node of the input graph, an indication of a distance between the given node and each of the other node of the plurality of nodes; generating a corresponding constrained binary quadratic programming problem using the generated distance table; providing the corresponding constrained binary quadratic programming problem to a quantum annealing solver; obtaining at least one approximate solution from the quantum annealing solver; post-processing the at least one approximate solution and providing the post-processed at least one approximate solution.

Abstract: The invention relates to an imaging device (E) comprising: at least one generator (1) of structured light; an emission first image guide (5, 5?) for uplinking the structured light from the generator (1) to an object to be observed; and a return second image guide (5?, 5) for downlinking the light reflected by said object to be observed to a system (2) for capturing said reflected light. Each of the two image guides (5, 5?) is able to uplink the structured light and downlink the reflected light, and the imaging device comprises an optical switch (3) configurable into three different operating modes.

Abstract: The present invention provides a rotary blood pump with both an attractive magnetic axial bearing and a hydrodynamic bearing. In one embodiment according to the present invention, a rotary pump includes an impeller assembly supported within a pump housing assembly by a magnetic axial bearing and a hydrodynamic bearing. The magnetic axial bearing includes at least two magnets oriented to attract each other. One magnet is positioned in the spindle of the pump housing while the other is disposed within the rotor assembly, proximate to the spindle. In this respect, the two magnets create an attractive axial force that at least partially maintains the relative axial position of the rotor assembly. The hydrodynamic bearing is formed between sloping surfaces that form tight clearances below the rotor assembly.

Abstract: A compound and the use thereof to prepare a functional or telechelic polyolefin is provided. The compound has the following formula (II): Y((CH2)p—B?)m??(II), wherein m=2 or 3; Y being an alkaline earth metal or zinc when m=2, Y being aluminum when m=3; B? being selected from the group comprising N(SiMe3)2; N(SiMe2CH2CH2SiMe2); C6F5; C3F7; C6F13; para-C6H4—NMe2; para-C6H4—O-Me; para-C6H4—N(SiMe3)2; and CH(OCH2CH2O); and p being an integer from 0 to 50.

Abstract: The invention related to isolated peptides including a binding domain of the viral phosphoprotein (P) subunit to the viral RNA free nucleoprotein (N0) which has the property to inhibit the replication of viruses from the subfamily Paramyxovirinae (like Henipavirus, Rubulavirus or Morbillivirus). These isolated peptides may be used for the prevention or the treatment of Paramyxovirinae infection.